Login / Signup

Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.

Rashmi RayTorben SchiffnerXuesong WangYu YanKimmo RantalainenChang-Chun David LeeShivang ParikhRaphael A ReyesGordon A DaleYing-Cing LinSimone PecettaSophie GiguèreOlivia SwansonSven KratochvilEleonora MelziIvy PhungLisa MadungweOleksandr KalyuzhniyJohn WarnerStephanie R WeldonRyan TingleEdward LampertiKathrin H KirschNicole PhelpsErik GeorgesonYumiko AdachiMichael KubitzUsha NairShane CrottyIan A WilsonWilliam R SchiefFacundo D Batista
Published in: Nature immunology (2024)
Current prophylactic human immunodeficiency virus 1 (HIV-1) vaccine research aims to elicit broadly neutralizing antibodies (bnAbs). Membrane-proximal external region (MPER)-targeting bnAbs, such as 10E8, provide exceptionally broad neutralization, but some are autoreactive. Here, we generated humanized B cell antigen receptor knock-in mouse models to test whether a series of germline-targeting immunogens could drive MPER-specific precursors toward bnAbs. We found that recruitment of 10E8 precursors to germinal centers (GCs) required a minimum affinity for germline-targeting immunogens, but the GC residency of MPER precursors was brief due to displacement by higher-affinity endogenous B cell competitors. Higher-affinity germline-targeting immunogens extended the GC residency of MPER precursors, but robust long-term GC residency and maturation were only observed for MPER-HuGL18, an MPER precursor clonotype able to close the affinity gap with endogenous B cell competitors in the GC. Thus, germline-targeting immunogens could induce MPER-targeting antibodies, and B cell residency in the GC may be regulated by a precursor-competitor affinity gap.
Keyphrases
  • human immunodeficiency virus
  • cancer therapy
  • hepatitis c virus
  • antiretroviral therapy
  • dna repair
  • hiv infected
  • hiv positive
  • zika virus
  • hiv testing
  • simultaneous determination
  • liquid chromatography